Mark Reddish
Direttore operativo presso Metrodora Therapeutics, Inc.
Provenienza dei contatti di primo grado di Mark Reddish
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 17 | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.
14
| Subsidiary | Medical Specialties | 14 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy
6
| Extinct | Medical/Nursing Services | 6 |
Metrodora Therapeutics, Inc.
1
| Private Company | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Reddish tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOVAVAX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer President | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
MIV Therapeutics, Inc.
 MIV Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services MIV Therapeutics, Inc. is an advanced stage, research and development company. It is engaged in developing a next-generation line of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents and for a broad range of other implantable medical devices. The company was founded by Alan P. Lindsay on January 20, 1999 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Public Communications Contact | |
| RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Operating Officer | |
| CRH MEDICAL CORPORATION | Medical/Nursing Services | Director/Board Member Director of Finance/CFO Corporate Secretary | |
| FEMASYS INC. | Electronic Equipment/Instruments | Director/Board Member | |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| TERRACE ENERGY CORP. | Oil & Gas Production | Chairman Corporate Secretary | |
| NEUROTROPE, INC. | Pharmaceuticals: Major | Chairman | |
Soloro Gold
 Soloro Gold Precious MetalsNon-Energy Minerals Soloro Gold engages in exploration and development of gold mining properties. The firm owns unpatented gold and mineral resource. Soloro Gold was founded on November 2, 2005 and is headquartered in Henderson, NV. | Precious Metals | Chief Executive Officer | |
| Q BIOMED INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Undergraduate Degree | |
Vertical Ventures LLC
 Vertical Ventures LLC Financial ConglomeratesFinance Vertical Ventures LLC provides investment and commercial real estate assets development services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded by Richard Kenneth Abbe. | Financial Conglomerates | Chief Investment Officer | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Chief Operating Officer | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Iroquois Capital LP
 Iroquois Capital LP Investment ManagersFinance Iroquois Capital LP engages in providing investment advice services. The company was founded by Joshua N. Silverman in 2002 and is headquartered in New York, NY. | Investment Managers | Chief Executive Officer | |
| The University of Chicago | College/University | Masters Business Admin Undergraduate Degree | |
| Lehigh University | College/University | Undergraduate Degree | |
| University of Alberta | College/University | Director/Board Member Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| University of Western Ontario | College/University | Masters Business Admin Undergraduate Degree | |
| MGT CAPITAL INVESTMENTS, INC. | Information Technology Services | Director/Board Member | |
Iroquois Capital Management LLC
 Iroquois Capital Management LLC Investment ManagersFinance Iroquois Capital Management LLC (Iroquois Capital) is an independent hedge fund management firm headquartered in Scarsdale, New York. The firm was founded by Ricahrd Abbe, Joshua Silverman and Scot Cohen in 2003. Iroquois Capital provides discretionary advice to funds that are formed as pooled investment vehicles. Investors in the funds include high net-worth individuals, family offices, pension plans and other institutional investors. | Investment Managers | Founder | |
The Workers' Compensation Board of Alberta
 The Workers' Compensation Board of Alberta Insurance Brokers/ServicesFinance The Workers' Compensation Board of Alberta operates as statutory corporation which administers the workers compensation system. It offers rate setting, assessment and collection of premiums from employers, payment of compensation benefits to injured workers, return-to-work services and administration. The firm’s compensation system covers injured workers for lost employment income, health care and rehabilitation services. The company was founded in 1918 and is headquartered in Edmonton, Canada. | Insurance Brokers/Services | Director/Board Member Director of Finance/CFO | |
| PHARMACYTE BIOTECH, INC. | Pharmaceuticals: Other | Chief Executive Officer | |
| NPX Metals, Inc. | Director/Board Member | ||
Joele Frank, Wilkinson Brimmer Katcher
 Joele Frank, Wilkinson Brimmer Katcher Miscellaneous Commercial ServicesCommercial Services Joele Frank, Wilkinson Brimmer Katcher provides public relations services. It offers corporate communication, investor relations, transaction communications, shareholder activism, crisis communication, and litigation support. The company was founded by Joele Frank in 2000 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| SYNAPTOGENIX, INC. | Pharmaceuticals: Major | Chairman | |
| Rutgers Business School | College/University | Undergraduate Degree Masters Business Admin | |
| Corin International | President | ||
| PROTAGENIC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
Parkfield Funding LLC
 Parkfield Funding LLC Investment ManagersFinance Parkfield Funding LLC provides capital management services. The private company is based in New York, NY. The company was founded by Joshua Nathaniel Silverman. | Investment Managers | Founder | |
| AYRO, INC. | Other Consumer Services | Chairman | |
Wigi Blockchain Technologies, Inc.
 Wigi Blockchain Technologies, Inc. Packaged SoftwareTechnology Services Wigi Blockchain Technologies, Inc. is a development stage payments technology company. It also provides retail and e-commerce businesses the ability to accept payments through cryptocurrency, which will charge a fee on every transaction. The company was founded on August 5, 2017 and is headquartered in Tokyo, Japan. | Packaged Software | Director/Board Member | |
| Fiduciary Trust Company International (13906) | Investment Managers | Corporate Officer/Principal | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Operating Officer | |
| FCTI, Inc. | Corporate Officer/Principal | ||
| Tapimmune, Inc. | Director/Board Member Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | ||
| MIRA PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman | |
| Taplmmune, Inc. | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 37 |
| Canada | 9 |
| Regno Unito | 3 |
| Austria | 2 |
| Belgio | 2 |
Settori
| Health Technology | 19 |
| Finance | 9 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 180 |
| Corporate Officer/Principal | 84 |
| President | 51 |
| Independent Dir/Board Member | 49 |
| Chairman | 48 |
Contatti più connessi
| Insiders | |
|---|---|
| Frank Holler | 29 |
| Michel Gréco | 28 |
| Joshua Silverman | 26 |
| James Fuller | 24 |
| David Laskow-Pooley | 22 |
| Todd R. Patrick | 22 |
| Sherry Grisewood | 19 |
| Frederick Wasserman | 19 |
| John N. Bonfiglio | 17 |
| Mustapha Bakali | 16 |
| Richard Kenney | 14 |
| Glynn Wilson | 13 |
| Patrick Yeramian | 13 |
| Peter Hoang | 12 |
| T. McPherson | 11 |
- Borsa valori
- Insiders
- Mark Reddish
- Connessioni Società
